SHE/300199 (SHE/300199)

Shenzhen Stock Exchange: SHE/300199 · CNY

CN¥23.2

-0.04 (-0.2%)· Recorded snapshot

Market cap	20.5B
Revenue (ttm)	1.5B
Net income (ttm)	401.9M
EPS (ttm)	CN¥0.44
Shares out	883.2M
P/E (trailing)	52.7x
Volume	34,957,035
Beta	0.69

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5B
Net income (ttm): 401.9M
EPS (ttm): CN¥0.44
P/E (trailing): 52.7x
Market cap: 20.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E52.7

P25 n/aP50 n/aP75 n/a

ROE45.6

P25 n/aP50 n/aP75 n/a

ROIC16.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/300199 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

CNY

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-27
Employees	1,226
Employees change	191
Employees growth	18.45%
Enterprise value	CNY 22.1B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CNE1000011T7
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2015-04-14
Last stock split type	Forward
Market cap	CNY 20.5B
Next earnings date	2026-10-30
Price	CNY 23.16
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	she/300199
Website	https://www.hybio.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.9%
EV/Earnings	55.09x
EV/EBIT	45.93x
EV/EBITDA	36.88x
EV/FCF	1,499.6x
EV/Sales	14.51x
FCF / EV yield	0.07%
FCF yield	0.07%
Graham number	3.39464
Graham upside	-85.34%
Industry forward P/E	18.72x
Industry P/E	33.27x
P/B ratio	18.84x
P/E ratio	52.66x
P/FCF ratio	1,385.66x
P/OCF ratio	59.89x
P/S ratio	13.41x
Price / tangible book value	27.11x
Price/EBITDA ratio	34.12x
Sector forward P/E	20.65x
Sector P/E	37.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	31.59%
EBITDA margin	39.3%
Effective tax rate	8.77%
FCF margin	0.97%
Gross margin	61.32%
Operating margin	31.59%
Pretax margin	28.7%
Profit margin	26.34%
Profit per employee	CNY 327,781
Profitable quarters	3
Profitable years	1
Revenue per employee	CNY 1.2M
ROA	8.46%
ROA (5Y)	-2.25%
ROCE	22.39%
ROE	45.6%
ROE (5Y)	-18.74%
ROIC	16.33%
ROIC (5Y)	-5.13%
Tax / revenue	2.52%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	67.74%
EPS growth 10Y	1.01%
EPS growth quarters	4
EPS growth years	2
FCF growth	-88.55%
FCF growth (Q)	-39.85%
FCF growth (QoQ)	-90.11%
Gross profit growth	89.37%
Gross profit growth (Q)	453.21%
Gross profit growth 3Y	39.13%
Gross profit growth 5Y	20.62%
Net income growth (QoQ)	83.62%
Net income growth quarters	4
Net income growth years	2
OCF growth	-1.66%
OCF growth (Q)	-35.81%
OCF growth (QoQ)	-68.99%
OCF growth 10Y	6.77%
OCF growth 5Y	19.04%
Operating income growth	266.25%
Revenue growth	69.87%
Revenue growth (Q)	314.48%
Revenue growth (QoQ)	42.39%
Revenue growth 10Y	5.12%
Revenue growth 3Y	38.45%
Revenue growth 5Y	23%
Revenue growth quarters	2
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -326.8M
Depreciation and amortization	CNY 117.5M
EBIT	CNY 481.9M
EBITDA	CNY 599.5M
EPS	CNY 0.44
FCF per share	CNY 0.02
Financing cash flow	CNY 11.1M
Free cash flow	CNY 14.8M
Gross profit	CNY 935.5M
Income taxes	CNY 38.4M
Investing cash flow	CNY -333.7M
Net borrowing	CNY 73.7M
Net cash flow	CNY 13.1M
Net income	CNY 401.9M
Operating income	CNY 481.9M
Revenue	CNY 1.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CNY 1.16
Debt / EBITDA	3.12
Debt / equity	1.73
Debt / FCF	126.89
Interest coverage	5.62
Long-term assets	CNY 2.8B
Long-term liabilities	CNY 1.1B
Net cash (debt)	CNY -1.7B
Net cash / market cap	-8.15%
Net debt / EBITDA	2.78
Net debt / equity	1.54
Net debt / FCF	112.96
Piotroski F-Score	6
Property, plant and equipment	CNY 1.9B
Shareholders' equity	CNY 1.1B
Tangible book value	CNY 754.4M
Tangible book value per share	CNY 0.82
Total assets	CNY 3.9B
Total cash	CNY 205.6M
Total debt	CNY 1.9B
Total liabilities	CNY 2.9B
WACC	7.72%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	CNY 1.1B
Current liabilities	CNY 1.8B
Current ratio	0.62
Inventory turnover	1.5
Net working capital	CNY 52.7M
Quick ratio	0.31
Working capital	CNY -681.2M
Working capital turnover	-1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.29%
Dividend growth (3Y)	44.22%
Dividend growth (5Y)	11.38%
Dividend per share	CNY 0.00
Last dividend	CNY 0.20
Payout ratio	24.24%
Shareholder yield	-3.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	8.89%
10Y return CAGR	1.05%
10Y total return	11.04%
150-day SMA	CNY 22.61
15Y price change	408.12%
15Y return CAGR	11.76%
15Y total return	429.74%
1D price change	-0.17%
1M price change	-0.6%
1M total return	-0.6%
1W price change	-12.6%
1W total return	-12.6%
1Y price change	6.29%
1Y return CAGR	6.29%
1Y total return	6.29%
20-day SMA	CNY 24.49
200-day SMA	CNY 21.65
3M price change	6.19%
3M total return	6.19%
3Y price change	42.09%
3Y return CAGR	12.42%
3Y total return	42.09%
50-day SMA	CNY 24.02
50-day SMA vs 200-day SMA	50over200
52-week high	CNY 27.70
52-week high date	2026-10-21
52-week low	CNY 16.23
52-week low date	2026-03-04
5Y price change	365.06%
5Y return CAGR	35.99%
5Y total return	365.06%
6M price change	3.44%
6M total return	3.44%
All-time high	CNY 52.76
All-time high date	2015-06-10
All-time low	CNY 2.79
All-time low date	2012-12-04
Average true range (ATR)	CNY 1.38
Average volume	58.2M
Beta (1Y)	0.6
Beta (2Y)	0.55
Beta (5Y)	0.69
Change from 52-week high	-16.39%
Change from 52-week low	42.7%
Change from all-time high	-56.1%
Change from all-time low	730.11%
Change from open	-4.85%
Day's gap	4.91%
Dollar volume	CNY 809.6M
High price	CNY 24.34
Low price	CNY 22.87
Monthly RSI	60.5
Open price	CNY 24.34
Position in 52-week range	19.73%
Previous close	CNY 23.20
Price vs 150-day SMA	2.43%
Price vs 20-day SMA	-5.42%
Price vs 200-day SMA	6.98%
Price vs 50-day SMA	-3.59%
Relative volume	0.59
RSI	43.56
Sharpe ratio	0.45
Sharpe ratio (3Y)	0.76
Sharpe ratio (5Y)	0.68
Sortino ratio	0.78
Sortino ratio (3Y)	1.25
Sortino ratio (5Y)	1.18
Volume	35M
Weekly RSI	51.32
YTD price change	29.39%
YTD total return	29.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	652.2M
Shares change (QoQ)	9.47%
Shares change (YoY)	3.29%
Shares held by insiders	24.69%
Shares held by institutions	6.59%
Shares outstanding	883.2M

Deeper analysis on SHE/300199

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/300199 report

Is a complete SHE/300199 research report available?

No complete published report is available for she/300199 (SHE/300199) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/300199 (SHE/300199)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300199

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300199 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300199

Frequently asked questions